Richard A. Byrd

475 total citations
23 papers, 375 citations indexed

About

Richard A. Byrd is a scholar working on Pediatrics, Perinatology and Child Health, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Richard A. Byrd has authored 23 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pediatrics, Perinatology and Child Health, 7 papers in Molecular Biology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Richard A. Byrd's work include Diabetes Treatment and Management (5 papers), Pancreatic function and diabetes (5 papers) and Effects and risks of endocrine disrupting chemicals (4 papers). Richard A. Byrd is often cited by papers focused on Diabetes Treatment and Management (5 papers), Pancreatic function and diabetes (5 papers) and Effects and risks of endocrine disrupting chemicals (4 papers). Richard A. Byrd collaborates with scholars based in United States and Germany. Richard A. Byrd's co-authors include J Buelke-Sam, C. J. Nelson, Joseph F. Holson, Paul C. Francis, B Main, Jamie L. Blackbourne, W. H. Jordan, R. Dustan Sarazan, John L. Vahle and Roger D. Meyerhoff and has published in prestigious journals such as Endocrinology, Toxicology and Applied Pharmacology and Toxicological Sciences.

In The Last Decade

Richard A. Byrd

23 papers receiving 359 citations

Peers

Countries citing papers authored by Richard A. Byrd

Since Specialization

Citations

This map shows the geographic impact of Richard A. Byrd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard A. Byrd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard A. Byrd more than expected).

Fields of papers citing papers by Richard A. Byrd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard A. Byrd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard A. Byrd. The network helps show where Richard A. Byrd may publish in the future.

Co-authorship network of co-authors of Richard A. Byrd

This figure shows the co-authorship network connecting the top 25 collaborators of Richard A. Byrd. A scholar is included among the top collaborators of Richard A. Byrd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard A. Byrd. Richard A. Byrd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nonclinical pharmacology and toxicology of the first biosimilar insulin glargine drug product (BASAGLAR®/ABASAGLAR®) approved in the European Union 2017 ·Regulatory Toxicology and Pharmacology ·Richard A. Byrd, Rebecca A. Owens, Jamie L. Blackbourne, David E. Coutant, Mark W. Farmen, M. Dodson Michael, Julie S. Moyers, A. Eric Schultze, Michael K. Sievert, Niraj Tripathi, John L. Vahle	4
2	Chronic Toxicology Studies of Basal Insulin Peglispro in Rats and Dogs: A Novel, PEGylated Insulin Lispro Analog with a Prolonged Duration of Action 2017 ·Toxicologic Pathology ·Richard A. Byrd, Jamie L. Blackbourne, Mary Pat Knadler, A. Eric Schultze, John L. Vahle	6
3	Effects of the GLP-1 Receptor Agonist Dulaglutide on the Structure of the Exocrine Pancreas of Cynomolgus Monkeys 2015 ·Toxicologic Pathology ·John L. Vahle, Richard A. Byrd, Jamie L. Blackbourne, Jennifer A. Martin, Steven D. Sorden, Thomas E. Ryan, Thomas P. Pienkowski, Thomas J. Rosol, Paul W. Snyder, Günter Klöppel	3
4	Chronic Toxicity and Carcinogenicity Studies of the Long-Acting GLP-1 Receptor Agonist Dulaglutide in Rodents 2015 ·Endocrinology ·Richard A. Byrd, Steven D. Sorden, Thomas E. Ryan, Thomas P. Pienkowski, Richard C. Larock, (unknown), John A. Wijsman, Holly W. Smith, Jamie L. Blackbourne, Thomas J. Rosol, Gerald G. Long, Jennifer A. Martin, John L. Vahle	21
5	The Selective Estrogen Receptor Modulator, Raloxifene: Segment II Studies in Rats and Rabbits 11These studies were conducted in accordance with the Food and Drug Administration “Good Laboratory Practice Regulations for Nonclinical Laboratory Studies” [1]. 1998 ·Reproductive Toxicology ·Richard A. Byrd, Paul C. Francis	16
6	The Selective Estrogen Receptor Modulator, Raloxifene: Reproductive Assessments in Adult Male Rats 11These studies were conducted in accordance with the Food and Drug Administration “Good Laboratory Practice Regulations for Nonclinical Laboratory Studies.” CRF Part 58, 1978. 1998 ·Reproductive Toxicology ·(unknown), (unknown), (unknown), Richard A. Byrd, Paul C. Francis	14
7	Developmental Toxicity of Dinitroaniline Herbicides in Rats and Rabbits I. Trifluralin 1995 ·Fundamental and Applied Toxicology ·Richard A. Byrd	23
8	Developmental Toxicity of Dinitroaniline Herbicides in Rats and Rabbits 1995 ·Toxicological Sciences ·(unknown), Richard A. Byrd, (unknown), John L. Emmerson	11
9	Simultaneous Differential Staining of Cartilage and Bone in Rodent Fetuses: an Alcian Blue and Alizarin Red S Procedure without Glacial Acetic Acid 1994 ·Biotechnic & Histochemistry ·(unknown), Richard A. Byrd	39
10	Developmental Toxicology Studies of Fluoxetine Hydrochloride Administered Orally to Rats and Rabbits 1994 ·Fundamental and Applied Toxicology ·Richard A. Byrd	50
11	Developmental Toxicology Studies of Vancomycin Hydrochloride Administered Intravenously to Rats and Rabbits 1994 ·Toxicological Sciences ·Richard A. Byrd, Christian L. Gries, Mildred K. Buening	2
12	Developmental Toxicology Studies of Fluoxetine Hydrochloride Administered Orally to Rats and Rabbits 1994 ·Toxicological Sciences ·Richard A. Byrd, (unknown)	4
13	Reproductive and developmental toxicity of the dopamine agonist pergolide mesylate in mice. 1994 ·PubMed ·(unknown), Richard A. Byrd, (unknown)	1
14	A Reproductive and Developmental Toxicity Study in CD Rats of LY275585, [Lys(B28),Pro(B29)]-Human Insulin 1994 ·Journal of the American College of Toxicology ·J Buelke-Sam, Richard A. Byrd, (unknown), (unknown)	21
15	Developmental Toxicology Studies of Vancomycin Hydrochloride Administered Intravenously to Rats and Rabbits 1994 ·Fundamental and Applied Toxicology ·Richard A. Byrd	11
16	A review of the toxicology of the antibiotic MICOTIL 300. 1993 ·PubMed ·W. H. Jordan, Richard A. Byrd, (unknown), (unknown), (unknown), B Main, Roger D. Meyerhoff, R. Dustan Sarazan	47
17	Developmental toxicity of the dopamine agonist pergolide mesylate in CD-1 mice. I: Gestational exposure 1991 ·Neurotoxicology and Teratology ·J Buelke-Sam, Richard A. Byrd, (unknown), Joseph P. Tizzano, (unknown)	10
18	Blood flow during pregnancy in the rat: III. Alterations following mirex treatment 1983 ·Teratology ·J Buelke-Sam, Richard A. Byrd, C. J. Nelson	14
19	Computer simulation of mirex pharmacokinetics in the rat 1982 ·Toxicology and Applied Pharmacology ·Richard A. Byrd, John F. Young, Carole A. Kimmel, Manford D. Morris, Joseph F. Holson	3
20	Altered pattern of prenatal toxicity in rats due to different treatment schedules with mirex 1981 ·Toxicology and Applied Pharmacology ·Richard A. Byrd, Carole A. Kimmel, Manford D. Morris, Joseph F. Holson, John F. Young	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact